Konstantinos Makrilakis1, Natasa Kalpourtzi2, Ioannis Ioannidis3, Stella Iraklianou4, Athanasios Raptis5, Alexis Sotiropoulos6, Magda Gavana7, Apostolos Vantarakis8, Maria Kantzanou2, Christos Hadjichristodoulou9, Grigoris Chlouverakis10, Grigoris Trypsianis11, Paraskevi V Voulgari12, Yannis Alamanos13, Giota Touloumi2, Stavros Liatis14. 1. Hellenic Diabetes Association, Athens, Greece; First Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens Medical School, Athens, Greece. Electronic address: kmakrila@med.uoa.gr. 2. Department of Hygiene, Epidemiology & Medical Statistics, National and Kapodistrian University of Athens Medical School, Athens, Greece. 3. Hellenic Diabetes Association, Athens, Greece; First Department of Internal Medicine and Diabetes Center, Konstantopoulio Hospital, Nea Ionia, Greece. 4. Hellenic Diabetes Association, Athens, Greece; Third Department of Internal Medicine, General Hospital Tzaneio, Piraeus, Greece. 5. Hellenic Diabetes Association, Athens, Greece; Second Department of Propaedeutic Internal Medicine, Research Unit and Diabetes Center, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece. 6. Hellenic Diabetes Association, Athens, Greece; 3rd Internal Medicine Department & Diabetes Center, General Hospital of Nikaia-Piraeus, Greece. 7. Dept of Primary Health Care, General Practice and Health Services Research, Medical School of Aristotle University, Thessaloniki, Greece. 8. Public Health, Medical School, University of Patras, Patra, Greece. 9. Dept of Hygiene and Epidemiology, Medical Faculty, University of Thessaly, Larisa, Greece. 10. Laboratory of Biostatistics, School of Medicine, University of Crete, Crete, Greece. 11. Laboratory of Medical Statistics, Medical School, Democritus University of Thrace, Thrace, Greece. 12. Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece. 13. Institute of Epidemiology, Preventive Medicine and Public Health, Corfu, Greece. 14. Hellenic Diabetes Association, Athens, Greece; First Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens Medical School, Athens, Greece.
Abstract
AIMS: To report the results of the first national Health Examination Survey (HES) on the prevalence of diabetes, its pharmacologic treatment and level of control, as well as pre-diabetes in Greece. METHODS: Data were derived from the National Survey of Morbidity and Risk Factors (EMENO), in a randomly selected, representative sample of the adult Greek population. Sampling weights were applied to adjust for study design and post-stratification weights to match sample age/sex distribution to the population. Non-response was adjusted by inverse probability weighting. Weighted prevalence estimates are provided. RESULTS: A total of 4393 persons with HbA1c and/or fasting plasma glucose measurements were included. Total diabetes prevalence was 11.9% (95% CI: 10.9-12.9), known diabetes 10.4% (9.5-11.4), and unknown 1.5% (1.1-1.9), with considerable increase in older age groups and no difference between genders. Pre-diabetes prevalence was 12.4% (11.4-13.6). The majority of persons with known diabetes were receiving metformin. Of those with known diabetes (and measured HbA1c), 70.9% were well controlled (HbA1c <7.0%). CONCLUSIONS: This first representative national HES showed high prevalence of diabetes in Greece, with low prevalence of unknown diabetes. Pre-diabetes prevalence is also substantial. These results will hopefully enable national authorities develop tailored and efficient strategies for disease prevention and management.
AIMS: To report the results of the first national Health Examination Survey (HES) on the prevalence of diabetes, its pharmacologic treatment and level of control, as well as pre-diabetes in Greece. METHODS: Data were derived from the National Survey of Morbidity and Risk Factors (EMENO), in a randomly selected, representative sample of the adult Greek population. Sampling weights were applied to adjust for study design and post-stratification weights to match sample age/sex distribution to the population. Non-response was adjusted by inverse probability weighting. Weighted prevalence estimates are provided. RESULTS: A total of 4393 persons with HbA1c and/or fasting plasma glucose measurements were included. Total diabetes prevalence was 11.9% (95% CI: 10.9-12.9), known diabetes 10.4% (9.5-11.4), and unknown 1.5% (1.1-1.9), with considerable increase in older age groups and no difference between genders. Pre-diabetes prevalence was 12.4% (11.4-13.6). The majority of persons with known diabetes were receiving metformin. Of those with known diabetes (and measured HbA1c), 70.9% were well controlled (HbA1c <7.0%). CONCLUSIONS: This first representative national HES showed high prevalence of diabetes in Greece, with low prevalence of unknown diabetes. Pre-diabetes prevalence is also substantial. These results will hopefully enable national authorities develop tailored and efficient strategies for disease prevention and management.
Authors: Vera Vik Bjarkø; Eirin B Haug; Elin P Sørgjerd; Lars C Stene; Paz Lopez-Doriga Ruiz; Kåre I Birkeland; Tore Julsrud Berg; Hanne Løvdal Gulseth; Marjolein M Iversen; Arnulf Langhammer; Bjørn Olav Åsvold Journal: Diabet Med Date: 2022-03-21 Impact factor: 4.213
Authors: Christina Vassou; Ekavi N Georgousopoulou; Christina Chrysohoou; Mary Yannakoulia; Christos Pitsavos; Mark Cropley; Demosthenes B Panagiotakos Journal: J Diabetes Metab Disord Date: 2021-05-18